Introduction
Nowadays, probiotics are used as an alternative for antibiotics since they are generally considered as safe and confer health benefits to the host. Probiotics produce antimicrobial molecules (e.g., lactic acid and bacteriocins) and enzymes, enabling them to function as an alternative to antibiotics owing to their antimicrobial effects toward pathogens [1] . Among probiotics, Lactobacillus is the most common probiotic because Lactobacillus has shown excellent antimicrobial activity against Salmonella spp. and Escherichia coli, which are major pathogens in livestock animals [2, 3] .
Lactobacillus reduces weight loss, improves feed intake and improves the growth performance of animals [4] . In our previous study, we isolated L. reuteri LRT18 from porcine feces and selected the highest antimicrobial effect on K88-positive Escherichia coli and Salmonella enterica subsp. [5] .
To deliver probiotics orally, many strategies target the intestine as a main location for the probiotics to provide the most beneficial effect to the host [6, 7] . Since the intestine has a neutral pH, long transit time and reduced host enzymatic activity, an intestine-specific drug delivery system increases the bioavailability of probiotics [8] . However, oral delivery of probiotics is extremely challenging Probiotics show low cell viability after oral administration because they have difficulty surviving in the stomach due to low pH and enzymes. For the oral delivery of probiotics, developing a formula that protects the probiotic bacteria from gastric acidity while providing living cells is mandatory. In this study, we developed tablets using a new pH-sensitive phthalyl inulin (PI) to protect probiotics from gastric conditions and investigated the effects of different compression forces on cell survival. We made three different tablets under different compression forces and measured survivability, disintegration time, and kinetics in simulated gastric-intestinal fluid. During tableting, there were no significant differences in probiotic viability among the different compression forces although disintegration time was affected by the compression force. A higher compression force resulted in higher viability in simulated gastric fluid. The swelling degree of the PI tablets in simulated intestinal fluid was higher than that of the tablets in simulated gastric fluid due to the pH sensitivity of the PI. The probiotic viability formulated in the tablets was also higher in acidic gastric conditions than that for probiotics in solution. Rapid release of the probiotics from the tablet occurred in the simulated intestinal fluid due to the pH sensitivity. After 6 months of refrigeration, the viability of the PI probiotics was kept. Overall, this is the first study to show the pH-sensitive properties of PI and one that may be useful for oral delivery of the probiotics.
Keywords: Probiotics, oral delivery, pH-sensitive tablet, phthalyl inulin because they can get destroyed and/or cause cell death due to stomach acid [9] . Therefore, delivering probiotics to the intestine safely while passing through harsh gastric conditions is of utmost importance in enabling probiotics to provide their therapeutic effect to the host. Recently, polymeric delivery systems have been attracting attention as a means to deliver biological materials, proteins, genes, and chemotherapeutics because they can deliver drugs to target sites [10] . Among many strategies for orally delivering probiotics, pH-sensitive polymers, such as hydroxypropyl methylcellulose phthalate (HPMCP) [11] , hydroxypropylmethyl cellulose acetated succinate [12] , and cellulose acetate phthalate (CAP) [13] have been used to protect probiotics from harsh gastric conditions since probiotics loaded into pH-sensitive polymers cannot be released in an acidic pH environment due to the deprotonated carboxylic acids in the polymers [14] . However, because these pHsensitive polymers only have the ability to protect probiotics from harsh gastric conditions, we designed a new type of pH-sensitive polymer using inulin as a prebiotic.
Inulin has been used as a prebiotic source in industrial applications because they are found in many natural sources (e.g., chicory root, Jerusalem artichoke, leek, and onion) [15] . Inulin consists of fructose polymers linked by β (2 → 1) bonds containing glucosyl moieties at the chain terminal. Due to the β (2 → 1) linkages in inulin, it is not digested by pancreatic enzymes in the upper GI tract [15] , although the gut microbiota can ferment inulin and produce short chain fatty acids (SCFAs), which induces the growth of beneficial microorganisms, thereby altering the composition of organisms in the gut microbiome and boosting the host immune system [16, 17] . Also, there has been a growing interest in the use of inulin as an adjuvant or drug delivery system. Interestingly, delta inulin in microparticle form showed adjuvanting ability for enhancing immune activity in vaccines against influenza, hepatitis B, etc.
[18], although soluble inulin has less immunological activity [19] .
In the health industry, there are several methods of formulating probiotics for use as food supplements and these include powder, liquid, and spray forms, although the most commonly used is powder. Although there have not been many reports, on creating a tablet form for oral delivery of probiotics one previous study did show that it is easy to formulate probiotics into tablet form with a pHsensitive polymer that successfully protected probiotics from harsh stomach conditions [20] .
In this study however, we aimed to develop a new pHsensitive tablet using phthalyl inulin (PI) to protect the L. reuteri LRT18 (LR) from harsh gastric conditions. Moreover, we obtained promising results for further in vivo application. To the best of our knowledge, this is the first report to exhibit the pH-sensitive properties of PI that protect probiotics from harsh gastric conditions.
Materials and Methods

Materials
L. reuteri LRT18 (LR, KCTC3594) used in this study was isolated from a previous study [5] . All of the materials and chemicals used in this study were purchased from Sigma-Aldrich (USA) unless otherwise stated. De Man, Rogosa and Sharpe agar (MRS) broth and MRS agar were purchased from BD Difco (Sparks, USA) for the bacterial cultures.
Synthesis of Phthalyl Inulin (PI)
Phthalyl inulin (PI) was synthesized as described in a previous report [21] . Briefly, 1 g of inulin (MW: 5,000 g/mol) was dissolved in 5 ml of N,N-dimethylformamide and 2.0 g of phthalic anhydride were added in the above solution and 0.2 ml of 5% (w/v) sodium acetate was used as a catalyst. The reaction was conducted at 40°C for 24 h under nitrogen gas. And then, the PI was dialyzed in cold water for 24 h. The PI was lyophilized and stored at -20°C until use. The conjugation of phthalyl groups in PI was confirmed by 600 MHz 1 H-NMR spectroscopy (AVANCE600, Bruker, Germany).
Tablet Preparation
LR cultures were grown in MRS broth at 37°C for 24 h and collected by centrifugation. Harvested cells were washed 3 times in phosphate buffer solution and suspended in 10% skim milk. The cells were then frozen at −20°C for 12 h and lyophilized. The lyophilized probiotics were ground into a fine powder and stored at 4°C until use. The tablets were prepared at room temperature (RT) by direct compression using a single press. For the tablets, a mixture of LR and PI (weight ratio of LR to PI = 1:1) was filled into a 4 mm diameter die. The tablets were formed under different pressures ranging from 3 to 10 kilopascal (KP) with a plane surface according to Tao et al. [20] .
Measurement of the Probiotic (LR) Viability and Disintegration Time of Tablets
The viability of LR in the tablet was expressed as colony forming units (CFU). Briefly, the tablets were broken and dispersed in 1 ml of phosphate buffer solution (PBS, pH 6.8). And then, the serial-diluted suspension was dropped into the MRS agar plate and incubated at 37°C to count the LR colonies according to the Tao et al. method [22] . The tablets were transferred into 5 ml PBS (pH 6.8) and the complete disintegration time was measured.
Measurement of the Swelling Ratio of Tablets
The tablets were transferred into 5 ml simulated gastric fluid (SGF) adjusted to pH 2 with pepsin (1,000 U/ml). The swelling ratio was calculated by the following equation [22] .
